Business · 12/05/1998Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 21 New Drug Applications and 62 Abbreviated New Drug Applications by Sanofi Pharmaceuticals, Inc., et al.
Summary
Sanofi Pharmaceuticals, Inc., et al. are having their 21 new drug applications (NDA's) and 62 abbreviated new drug applications (ANDA's) withdrawn by the FDA due to the drugs no longer being marketed, as requested by the applicants.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →